Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
批准号:
7908303
负责人:
DAVID H WALKER
金额:
$93.23万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-12 至 2011-08-31
中文摘要
描述(由申请人提供):西部地区生物防御和新发传染病研究卓越中心(WRCE)的使命是创建协同、多方面的研究、强大的基础设施,以及通过应用最好的基础科学和翻译科学来开发针对自然和人为新发传染病威胁的疫苗、疗法和诊断方法的活动。来自22个机构的科学家建议开展15个重大研究项目,并提供6项支持性核心活动。WRCE是德克萨斯州、新墨西哥州、俄克拉何马州、阿肯色州和路易斯安那州合作研究传染病的联合力量。对国家RCE计划的评估显示,WRCE在生物防御方面的新调查人员数量、项目数量、研究的生物体数量、专利申请数量以及来自RCE项目的其他资金支持的新项目数量方面表现最好。成功的基础科学家在A-C类代理方面拥有丰富的专业知识,他们真正接受了面向翻译产品的研究这一陌生目标。这15个主要项目涉及四个主题:RNA病毒治疗试剂的开发,A-C类药物和新兴药物的多重诊断平台,虫媒病毒和新出现的病毒疾病的疫苗开发,以及细胞内细菌引起的疾病的疫苗开发。这15个项目目前正在追求新的具体目标;这是世界资源、环境和经济委员会在上一个赠款周期中支持发展型赠款以启动下一阶段项目的战略的结果,以及在周期结束前一年对主要项目的提前竞争。在这一规划过程中,可以选择最好、最相关的科学,并在主题范围内发展协同作用。行政核心对进度报告、现场访问、区域会议、讲习班和正式的外部产品开发协商的分析提供认真指导,支持研究活动,并每月举行主题会议,以确保项目继续取得成功。高生产率的科学家利用地区来源,如三个国家灵长类研究中心,19个拥有BSL-3实验室的机构,两个拥有BSL-4实验室的机构,两个疫苗开发中心,两个能源部国家实验室,13所参与的医科大学,三所参与的兽医学校,以及四个拥有空气生物学专业知识的机构,将他们杰出的科学知识转化为一个比其部分总和更多的计划。
相关性:西部地区生物防御和新发传染病研究卓越中心科学计划支持国家为传染病病原体开发新药、诊断和疫苗的努力。应急准备计划还确保在发生生物恐怖事件或自然爆发期间提供设施和专题专门知识。
战略管理计划说明:
行政核心负责西部地区生物防御和新发传染病研究英才中心(WRCE)的全面管理和协调。它提供治理、财务监督和运营管理职能,以促进战略研究计划的执行,从而使WRCE能够履行其使命,为A、B、C类和新出现的传染病传染病病原体开发新的诊断、治疗和疫苗。具体职能包括:(1)制定管理世界研究中心业务的政策;(2)管理财政资源;(3)协调常设咨询委员会的活动;(4)监督研究项目和核心设施;(5)执行重大研究项目、发展研究项目、职业发展项目的研究方案;(6)促进科学家、机构官员和外部团体之间的交流和信息传播;(7)协调研究丰富活动;(8)管理年度战略规划进程;(9)维护记录,编写报告和年度续展申请;以及(10)制定区域应急预案。行政核心还设有一名产品开发副主任。该人员帮助确定翻译研究资助机会,并指导项目负责人解决项目进展中的监管问题,同时也是WRCE产品开发工作组的主席。管理活动在指导委员会、政策咨询委员会、外部咨询委员会、地区议会、个别研究项目和核心领导以及世界资源研究中心的其他关键人员的建议下进行,所有这些都与NIAID的生物防御计划管理者密切合作。电话会议和视频会议被最大限度地用于促进德克萨斯大学医学部和RCE生物防御网中的其他机构之间的沟通。相关性(见说明):WRCE管理核心为西部地区生物防御和新发传染病研究卓越中心的项目提供全面管理和协调。科学计划和应急准备计划支持国家为传染病病原体开发新药、诊断或疫苗的努力。
英文摘要
DESCRIPTION (provided by applicant): The mission of the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE) is the creation of synergistic,.multifaceted research, strong infrastructure, and activities to develop vaccines, therapeutics, and diagnostics against natural and manmade emerging infectious disease threats by applying the best basic and translational science. Scientists from 22 institutions propose to conduct 15 major research projects and provide six supportive core activities. The WRCE is a unifying force in Texas, New Mexico, Oklahoma, Arkansas, and Louisiana for collaborative research on infectious diseases. The evaluation of the national RCE program revealed that the WRCE was the top performer in the number of new investigators in biodefense, number of projects, number of organisms studied, number of patents filed, and number of new projects supported by other funds that stemmed from RCE projects. Successful basic scientists with substantial expertise in Category A-C agents have truly embraced the unfamiliar goal of translational product-oriented research. The 15 major projects address four themes: development of therapeutic agents for RNA viruses, platforms for multiplexed diagnostics for Category A-C agents and emerging agents, vaccine development for arboviral and emerging viral diseases, and vaccine development for diseases caused by intracellular bacteria. The 15 projects are currently pursuing new specific aims; this is a result of the WRCE's strategy in the previous grant cycle to support developmental type grants to initiate next-stage projects, and an early competition for major projects one year before the completion of the cycle. This planning process allowed selection of the best, most relevant science and development of synergistic interactions within the themes. Attentive guidance by the administrative core's analysis of progress reports, site visits, regional meetings, workshops, and formal external product development consultations support research activities, along with monthly theme meetings to ensure the continued success of projects. Highly productive scientists utilize such regional sources as three national primate research centers, 19 institutions with BSL-3 laboratories, two institutions with BSL-4 laboratories, two vaccine development centers, two DOE national laboratories, 13 participating medical universities, three participating veterinary schools, and four institutions with aerobiology expertise to translate their outstanding scientific knowledge into program that delivers more than the sum of its parts.
RELEVANCE: The Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research scientific program supports the national effort toward developing new drugs, diagnostics, and vaccines for infectious disease agents. The emergency response preparedness plan also ensures that facilities and subject matter expertise will be provided during a bioterror event or naturally occurring outbreak.
STRATEGIC MANAGEMENT PLAN DESCRIPTION:
The Administrative Core is responsible for the overall management and coordination of the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE). It provides governance, financial oversight, and operational management functions to facilitate the execution of the strategic research plan, thereby enabling the WRCE to fulfill its mission to develop new diagnostics, therapeutics and vaccines for Category A, B, and C and emerging infectious disease infectious agents. Specific functions include: (1) the development of policies governing WRCE operations; (2) management of financial resources; (3) coordination of activities of standing advisory committees; (4) oversight of research projects and core facilities; (5) implementation of research programs for major Research Projects, Developmental Research projects, Career Development projects; (6) facilitation of communication and information dissemination among scientists, institutional officials, and external groups; (7) coordination of research enrichment activities; (8) management of the annual strategic planning process; (9) maintenance of records and preparation of reports and annual continuation applications; and (10) development of the regional Emergency Response Plan. The Administrative Core also has an Associate Director of Product Development. This individual helps identify translational research funding opportunities and guides project leaders through regulatory issues as projects advance, and also chairs the WRCE Product Development Working Group. Management activities are carried out with the advice of the Steering Committee, a Policy Advisory Board, an External Advisory Board, a Regional Council, individual research project and core leaders, and other key personnel of the WRCE, all in close collaboration with NIAID's biodefense program administrators. Teleconferencing and videoconferencing are maximally utilized to facilitate communication between the University of Texas Medical Branch, the lead institution for the WRCE, and other institutions in the RCE Biodefense Network. RELEVANCE (See instructions): The WRCE Administrative Core provides overall management and coordination of the programs for the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research. The scientific program and emergency response preparedness plan support the national effort toward developing new drugs, diagnostics, or vaccines for infectious disease agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8392057
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8377041
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8377034
-
项目类别:
-
资助金额:$58.39万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8377037
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8495268
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8233011
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8233007
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8233008
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8042570
-
项目类别:
-
资助金额:$93.69万
-
财政年份:2010
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:7676462
-
项目类别:
-
资助金额:$71.89万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:7676511
-
项目类别:
-
资助金额:$72.83万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:7676456
-
项目类别:
-
资助金额:$72.2万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7716083
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
EXPERIMENTAL INFECTION OF THE MARMOSET WITH LASSA VIRUS
-
批准号:7716110
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER BIVALENT VACCINE EFFICACY IN MARMOSETS
-
批准号:7716131
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7716059
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
WRCE Administrative Core
-
批准号:7649683
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7562433
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7562462
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
Vaccine for Epidemic Typhus
-
批准号:7149656
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2006
-
负责人:DAVID H WALKER
-
依托单位:
海外基金